Northern Blot Analysis. RNA was denatured and electrophoresed as described by Lehrach et al. (26) . Total RNA (0.5 mg/ml) was denatured at 60°C for 15 min. 5 #g of RNA was then electrophoresed through 1.5% agarose gels buffered with 10 mM phosphate, 5 mM NaOAc, 1 mM EDTA, and containing 3% formaldehyde. Fractionated RNA was transferred to nitrocellulose in 20X SSC (3 M NaCI, 0.3 M sodium citrate, pH 7.0) and baked at 80°C. Hybridization was carried out using buffers essentially described by Wahl et al. (27) . Prehybridization buffer contained 50% formamide, 5x SSC, 4x Denharts, 150 •g/ml herring sperm DNA, 100 mM NaH~PO4, 1% glycine, and 50 t~g]ml polyadenylic acid (poly A). Prehybridization was for 2 h at 45 °C. Hybridization buffer contained four parts prehybridization buffer and one part 50% (wt/vol) dextran sulfate. Hybridization was performed at 45°C for 16-18 h with 106 cpm/ml denatured, nick-translated (28) , SAA-specific cDNA (10 s cpm/#g) isolated from pSAA~. RNA blots were washed three times at room temperature with 2x SSC, 0.1% SDS for 20 min each, followed by three washes in 0.1x SSC, 0.1% SDS at 55°C for 15 rain each. Comparison of SAA~.2.3 mRNA sequences (John F. Morrow, personal communication; 23) revealed that SAA~ and SAA2 are highly conserved with 96% homology. SAA3 mRNA is 73% homologous to SAA~ mRNA, but contains a 150-nucleotide region of 90% homology to our pSAA~ cDNA. Using these standard blot washing conditions, regions of ~90% homology would form stable hybrids. 28S and 18S RNA were visualized on the nitrocellulose after autoradiography of the blot by staining in 0.04% methylene blue in 0.5 M sodium acetate, pH 5.5.
Results

Time Course of Amyloid Deposition.
The changes with time of the relative volume of splenic tissue occupied by amyioid substance is shown in Fig. 1 . With either Congo red or H & E staining, no amytoid material was detected until day 5, at which time ~2% of splenic volume was occupied. The quantity of amyloid substance increased rapidly thereafter, and by day 20 represented ~30% of the total spleen volume.
There is No Detectable Synthesis of SAA by the Spleen. In order to determine whether or not spleen cells contribute to amyloid substance accumulation via SAA synthesis and secretion, a recombinant SAA cDNA, which hybridizes to,all three SAA sequences, was used to detect SAA mRNA. Fig. 2 shows the result of hybridizing the ~P-labeled SAA cDNA to liver RNA, which synthesizes large amounts of SAA in response to inflammatory stimuli, and spleen RNA after electrophoresis through agarose and transfer to nitrocellulose. Liver SAA mRNA was elevated to a high level 1 d after casein injection (lanes 1 and 2). No SAA 20 Doys FIGURE I. Time course of amyloid deposition. At the indicated times spleens were removed and prepared for histological examination. As described in Materials and Methods, amyloid cross-sectional area was computed by morphometry. Time points represent mean percentages from four fields of each of four spleens. FIGURE 2. Northern gel analysis of liver and spleen RNA. Total RNA from liver and spleen was isolated at various times during amyloid induction. 5 #g of RNA were then separated on agarose (1.5%) formaldehyde denaturing gels, transferred to nitrocellulose, and the nitrocellulose filter was hybridized to nick translated SAA cDNA as described in Materials and Methods. The RNA examined was extracted from the following tissues: Lane 1 and 2 are liver from either uninjected animals (lane 1) or 1 day after casein injection (lane 2). Lanes 3 -6 were from spleens from uninjected animals (lane 3) or from animals after 7, 14 and 21 d of casein injections, respectively. The position of the 28s and 18s ribosomal RNA is indicated.
mRNA was detected in spleen of control animals or during amyloid substance deposition (lanes [3] [4] [5] [6] . Quantitative Northern blot analysis at a sensitivity capable of detecting ~> 1% of normal liver SAA mRNA did not reveal splenic SAA mR NA (data not shown). In addition, no SAA products could be detected from the cellfree translation of splenic RNA (data not shown). Furthermore, no SAA mRNA was detected after casein injection in a variety of other tissues examined (unpublished observation).
Circulating Levels of SAAs. Serum SAA levels 1 d after the first casein injection (Fig. 3) , were elevated >50-fold above baseline (280 ___ 58 #g/ml). Thereafter, SAA levels remained elevated but slowly declined to a low of ~110 + 35 #g/ml by day 15 and remained at this level despite continued casein injections.
Analysis of SAA~ and SAA2 levels revealed that on day 1 SAAI was 120 ~g/ml while SAA2 was 160 #g/ml (SAA2/SAA1 ratio, 1.98). Over the next 19 d SAAI dropped slightly to 100 #g/ml while the SAA2 level dropped dramatically to 15 #g/ml (SAAz/SAA~ ratio, 0.15). A second similar experiment (data not shown) yielded essentially the same result, although total serum SAA rose to only 190 gg/ml, the SAA~/SAA~ ratio declined with similar kinetics from 1.4 on day 1 to 0.12 on day 20.
Changes in Hepatic SAA~ and SAA2 mRNA Assayed by Celt-free Translation. In order to measure hepatic SAA~ and SAA2 mRNA levels, we first determined [35S]methionine, SAA antibody-precipitated translation products were separated on SDS-ureapolyacrylamide gels and radiofluorographs prepared (as in top). SAAI and SAA~ preproteins were quantitated by microdensitometry of appropriately exposed fluorographs. The number at the top of the bars is the SAA2/SAA~ preprotein ratio. RNA from two livers at each time point was analyzed.
were specifically immunoprecipitated in approximately equal amounts (Fig. 4a,  lanes 1 and 2) , and as expected of preproteins, migrated with mobilities of peptides appropriately larger than SAA~ and SAA2. Pretreatment of the antibody with murine protein AA completely blocked antibody precipitation of the translated proteins (lane 3). Fig. 4b depicts results of cell-free translations of total RNA in the absence (lane 1) or presence (lane 2) of microsomes (which remove the NH2 terminal signal peptide from secretory proteins) (29) . As in Fig. 4a , two SAA preproteins are immunoprecipitated from the reaction. Translations carried out in the presence of microsomes result in processed SAA proteins with the same mobility as authentic SAAI and SAA2 isolated from HDL.
The relative abundance of hepatic SAAI and SAA2 mRNA was determined by quantitation of [aSS]methionine-labeled SAA1 and SAA2 preproteins, identified after cell-free translation of liver mRNA obtained from animals over the time course of amyloid induction. Fig. 5 (top) shows the following: no specific radioactivity was precipitated in translation products from uninduced animals (lane 1). One day after casein injection, SAA translation products were easily detected and represented -3.4% of total TCA precipitable counts translated. The level of SAA translation products showed a gradual decline and by day 20 was ~30% of that at day 1. As shown in Fig. 5(bottom) , the relative SAAI and SAA2 preprotein levels did not change significantly over the course of the amyloid deposition (day 1, 1.36; day 20, 1.23). This result is in contrast to the ratios of circulating SAAz/SAAI shown in Fig. 2 , and clearly shows that the SAA1 and SAA2 mRNA ratio is not altered during amyloidogenesis.
Synthesis and Secretion of SAA by Hepatocytes In Vitro. Although hepatic SAA1
and SAA2 mRNA ratios remained unchanged during amyloid deposition, the relative rates of mRNA translation or relative efficiency of secretion may be changed and result in altered SAA2 to SAA~ ratio in the circulation. We obtained information on the relative rates of secretion of each SAA isotype by intact hepatocytes from freshly isolated hepatocytes 1 and 20 d after initiation of casein injections (Fig. 6) . Proteins secreted into the medium during a 4-h labeling period with [~SS]methionine were separated by SDS-urea-PAGE and the quantity of SAA1 and SAA2 estimated by microdensitometry of appropriately exposed autoradiographs (data not shown). Although the amount of each SAA isotype secreted by hepatocytes after 20 d of casein injection was reduced to ~25% of that secreted after day 1, the ratio of SAA2/SAA1 on day 1 and day 20 was the same (1.27 ). This result is in good agreement with the relative levels of SAA~ and SAAz mRNA (Fig. 4) , and taken together these data show that SAAL and SAAz mRNA levels and their synthesis and secretion by the liver decline in a parallel manner during induction of amyloidosis by multiple casein injections.
Discussion
Amyloidosis of the reactive variety may complicate chronic inflammatory diseases such as rheumatoid arthritis and tuberculosis (2) . Extracellular amyioid deposits composed of fibrils accumulate in extracellular locations in a variety of tissues, resulting in organ dysfunction (!-3, 12, 30-37 ). The fibrils are composed mainly of protein AA, an 8.5-kD peptide homologous with the NH2-terminal portion of the acute-phase HDL-associated apoprotein, serum amyloid A protein.
What is the underlying cause of amyloid formation? The commonly accepted hypothesis of amyloid deposition is that amyloid fibril protein A is derived from circulating SAA because of its sustained high levels during chronic inflammatory conditions. However, no certain evidence has been produced to sustain this supposition. Although an elevated SAA level is a predisposing condition for amyloid formation, high SAA levels alone are not sufficient. Of patients with chronic inflammatory diseases, only some individuals develop amyloidosis (2) . Mouse model systems do not show a 1:1 correlation between SAA level and susceptibility to amyloid deposition (13, 38) . Therefore, it appears that factors other than high SAA levels are involved in the pathogenesis of amyloidosis.
Our recent evidence that murine protein AA is derived from only one SAA isotype (12) indicates that an important feature of murine amyloidosis involves a mechanism specific for SAA2 deposition. SAA2 overproduction could result in ineffective degradation during normal catabolic mechanisms, or SAA1 synthesis could cease during the long inflammatory period of amyloid deposition, leaving only SAA2 as a possible circulating precursor to AA protein. Another possibility is that structural features of the SAA2 protein alone may confer amyloidogenic potential without the need for altered metabolic pathways, or that SAA2 could be synthesized and deposited locally rather than derived from the circulation as suggested by other investigators (39) (40) (41) (42) (43) (44) (45) , and as is the case in endocrine and cutaneous amyloidosis (46) . In order to differentiate among the several possible mechanisms of amyloidosis, we searched for evidence of local SAA synthesis and examined SAA metabolism during amyloid induction at the level of SAA gene expression, synthesis, and secretion and circulatory levels.
Having used a probe capable of detecting all three expressed SAA genes (Fig.  2) , our findings that at no time during amyloid formation does splenic tissue contain detectable levels of SAA mRNA leave no doubt that the source of AA protein in the mouse is not local, but must be sequestered from the circulation. In addition, to determine if tissues other than liver synthesized SAA, we searched for SAA mRNA in RNA extracted from lung, heart, kidney, brain, skeletal muscle, and testis. We did not detect SAA mRNA in normal controls or at any time during amyloid induction in these tissues.
Our analysis of circulating SAA showed that monotypic amyloid formation is not a reflection of circulating SAA2 levels, either by having a large preponderance of SAA2 compared with SAAj or by the lack of circulating SAAj. In fact, SAA2 serum levels are substantially reduced during the course of amyloid formation. This could be due to differential isotype synthesis and secretion or altered clearance from the circulation. However, the relative levels of SAA1 and SAA2 mRNA remained constant (Fig. 5) , as did the amounts of SAAl and SAA2 synthesized and secreted by hepatocytes (Fig. 6) . The tenable explanation, therefore, is that SAA2 is removed from the circulation faster than SAA~. This differential clearance of SAA isotypes is in marked contrast to equal clearance rates of SAA1 and SAA2 observed in normal mice (47) and mice during an acute phase response (Hoffman, Jeffrey S., unpublished observation). Thus protein AA monotypy in murine amyloid deposits must be the result of events that favor the rapid local removal of SAA2 from a circulating pool containing both SAA1 and SAA2.
Several factors may make SAA2 amyloidogenic. The structure of the SAA2 polypeptide may be important for amyloid deposition. Comparison of mouse SAA~ and SAA2 sequences deduced from cloning data (Morrow, John F., personal communication) (23) reveals nine relatively conservative amino acid residue differences. Among them is a third methionine residue at position 76 in SAA2. Our amino acid analysis data (34) indicate that this third methionine is included in the murine protein AA polypeptide (the NH2 terminal portion of SAA2, ~8.5 kD). It is of interest that in an autosomal dominant form of genetically determined amyloidosis, familial amyloidotic polyneuropathy (FAP), a variant transthyretin is synthesized with a methionine substitution for a valine. Both the normal and variant proteins are found in the circulation, but only the variant transthyretin accumulates as amyloid fibrils (48, 49) . This suggests that in the local environment where amyloid deposits occur, an additional methionine residue may confer increased protein-cell and/or protein-protein affinities. However, the significance of an additional methionine residue or other amino acid differences between SAAz and SAA~ awaits further investigation. In addition, further studies are necessary to elaborate the details surrounding the nature of the interaction of SAA2, leading to its rapid and selective removal from the circulation and resulting in local amyloid deposition.
Summary
The deposits of fibrils found in amyloidosis of the A type are derived from only one of the three serum amyloid A (SAA) gene products, namely SAA2. In order to explore the mechanism of SAA isotype-specific amyloid protein AA deposition, the molecular kinetics of the serum amyloid proteins were examined in CBA mice during casein induction of amyloidosis. The presence of SAA mRNA in spleen was searched for; hepatic SAA1 and SAA2 mRNA levels, rates of specific protein synthesis and secretion by hepatocytes, and serum levels were measured during a 20-d period of amyloid induction. We observed the following: small amounts ofamyloid substance appeared in the spleen by day 5 and increased steadily over the ensuing 15 d to occupy nearly 30% of splenic volume by day 20. No SAA mRNA was detected in spleen at any time during induction of amyloid formation. Total serum SAA levels peaked 1 d after we began casein treatment, and thereafter declined. This decline was accounted for entirely by a dramatic fall in SAA2, while SAA1 levels remained nearly constant throughout.
The ratios of hepatic SAA2:SAA~ mRNA, as determined by in vitro translation, remained constant during the 20-d period, as did amounts of SAA, and SAA2 synthesized and secreted by freshly isolated hepatocytes. These data indicate that the deposition of amyloid A protein derived from SAA2 is not due to local SAA production in spleen, nor excessive SAA2 production compared with SAA,, but involves the selective and accelerated removal of SAA2 from the circulating pool of both SAA~ and SAA2.
